Trinity Biotech Plc (TRIB)
5.91
+0.22
(+3.87%)
USD |
NASDAQ |
Oct 05, 16:00
6.10
+0.19
(+3.21%)
After-Hours: 20:00
Trinity Biotech Gross Profit Margin (Quarterly) : 0.00% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00% |
| December 31, 2025 | 32.05% |
| September 30, 2025 | 42.72% |
| June 30, 2025 | 39.45% |
| March 31, 2025 | 20.67% |
| December 31, 2024 | 30.07% |
| September 30, 2024 | 32.80% |
| June 30, 2024 | 34.82% |
| March 31, 2024 | 33.97% |
| December 31, 2023 | 30.59% |
| September 30, 2023 | 28.78% |
| June 30, 2023 | 34.90% |
| March 31, 2023 | 35.89% |
| December 31, 2022 | 32.81% |
| September 30, 2022 | 0.40% |
| June 30, 2022 | 34.81% |
| March 31, 2022 | 37.65% |
| December 31, 2021 | 33.40% |
| September 30, 2021 | 39.40% |
| June 30, 2021 | 41.12% |
| March 31, 2021 | 41.86% |
| December 31, 2020 | 46.86% |
| September 30, 2020 | 51.46% |
| June 30, 2020 | 40.38% |
| March 31, 2020 | 41.91% |
| Date | Value |
|---|---|
| December 31, 2019 | 43.50% |
| September 30, 2019 | 40.95% |
| June 30, 2019 | 41.95% |
| March 31, 2019 | 42.40% |
| December 31, 2018 | 41.73% |
| September 30, 2018 | 42.09% |
| June 30, 2018 | 43.23% |
| March 31, 2018 | 43.82% |
| December 31, 2017 | 41.47% |
| September 30, 2017 | 42.95% |
| June 30, 2017 | 42.51% |
| March 31, 2017 | 42.02% |
| December 31, 2016 | 40.03% |
| September 30, 2016 | 44.66% |
| June 30, 2016 | 44.95% |
| March 31, 2016 | 43.08% |
| December 31, 2015 | 43.18% |
| September 30, 2015 | 46.52% |
| June 30, 2015 | 46.97% |
| March 31, 2015 | 47.94% |
| December 31, 2014 | 47.47% |
| September 30, 2014 | 47.90% |
| June 30, 2014 | 48.10% |
| March 31, 2014 | 48.60% |
| December 31, 2013 | 47.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 15.62% |
| Akari Therapeutics Plc | -- |
| Autolus Therapeutics Plc | 55.20% |
| Evaxion AS | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.37% |
| Return on Invested Capital | -51.65% |
| Profit Margin (Quarterly) | -40.74% |
| Operating Margin (Quarterly) | -26.60% |
| Return on Net Operating Assets | -35.90% |